Hard Decoupling: Foreign Firms Less Optimistic About China But Health Sector Revenues Growing

IP, Cybersecurity Concerns Prominent

Latest US trade group business survey shows R&D-based pharma and medical device companies continue to see China as an important growth driver but amid unequal market access, ongoing regulatory concerns, and patchy IP protection improvements.

American Chamber of Commerce report show foreign companies are less optimistic about investing in China but health players continue to grow
AMCHAM CHINA LATEST REPORT SHOWS FOREIGN BUSINESS LESS OPTIMISTIC ABOUT CHINA INVESTMENT BUT HEALTH PLAYERS CONTINUE GROWING • Source: Alamy

Despite a cooling of foreign companies’ overall investment enthusiasm in China, nearly half of pharma and medical device companies surveyed by a US trade group say the quality of the country’s investment environment is actually improving.

46% of respondents to the annual business climate survey conducted by the American Chamber of Commerce in China (AmCham China)...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Asia